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With a large number of subjects in the population being at a high risk for cardiovascular diseases (CVDs), simple markers are needed for assessing the risk for future CVDs. Several risk assessment models based on data obtained from general health checkups are available, such as the Framingham risk score and Suita score. The Japan Atherosclerosis Society guidelines for the prevention of atherosclerotic diseases recommend the use of the Suita score for assessing the risk of CVDs^[@bib1])^. However, a reasonable estimate is that the major established risk factors explain only approximately 75% of the occurrences of coronary heart disease events within populations^[@bib2])^. To overcome this limitation, the multiple marker approach (i.e., the use of risk prediction model in combination with other markers) has been proposed^[@bib3])^. While the usefulness of several markers in combination with the conventional risk prediction models for the evaluation of CVD risk has been examined, none has been established as being useful so far^[@bib3])^. As mentioned above, because of the large population that needs CVD risk assessment, the availability of marker(s) that are simple to measure is important. The carotid intima-media thickness (IMT) is a simple-to-measure marker to assess the severity of carotid atherosclerosis^[@bib4])^. Atherosclerosis is characterized by focal rather than diffuse lesions in the arterial wall. However, to satisfy the criteria of simplicity of measurement and applicability to large populations as a marker to assess the risk of CVD, carotid IMT is measured as a fixed-point observation. This could underestimate the severity of carotid atherosclerosis in some cases. Meta-analyses conducted to examine whether carotid IMT is an independent predictor of future CVD events have reported inconsistent results^[@bib5],\ [@bib6])^.

In this issue, Tada *et al.* reported that the plaque score rather than carotid IMT may be a more reliable independent predictor of future CVD events in subjects with a history of CVDs (i.e., a marker for secondary prevention)^[@bib7])^. Plaque score may also be a more reliable marker for the severity of carotid atherosclerosis than carotid IMT because the plaque score reflects the severity of atherosclerosis in focal lesions. Plaque score is based on ultrasound examination, which provides two-dimensional images of a three-dimensional lesion. Therefore, in Tada\'s study, trained sonographers assessed the carotid plaque score with acceptable reproducibility and generalizability^[@bib7])^. Recently, however, ultrasound techniques that provide three-dimensional images have become available in clinical practice, which may improve the reproducibility and generalizability of the assessment of carotid plaques in general practice. Most of Tada\'s study subjects presented a history of CVD and may therefore have had advanced atherosclerosis. Furthermore, in Tada\'s study, the prevalence of heart disease was higher than that of stroke. Therefore, they speculated that the carotid plaque score reflects the total atherosclerotic burden in the systemic arterial tree, which might contribute to CVD events. On the other hand, Zureik *et al.* reported that carotid plaques, but not the common carotid IMT, was independently associated with the aortic stiffness, an independent risk factor for future CVD events^[@bib8])^. Apart from the total atherosclerotic burden, increased arterial stiffness is thought to mediate CVD events via inducing hemodynamic abnormalities^[@bib9])^. In addition, van Sloten *et al.* reported from their meta-analysis of studies conducted in the general population (i.e., subjects with less advanced atherosclerosis) that the carotid arterial stiffness, assessed as stiffness index beta, is a predictor of future stroke but not of coronary heart diseases^[@bib10])^. They speculated that high blood pulsatility rather than the severity of atherosclerosis causes stroke. Thus, the next logical step is to clarify whether the carotid plaque score rather than carotid IMT is a more reliable predictor of stroke as well as coronary heart disease in subjects without a past history of cardiovascular disease.
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